The overall impression of the IOM committee is that these trials were ethically sound clinical research projects designed and carried out by highly competent investigators who frequently went beyond the requirements dictated by regulations or imposed by IRBs to respond to the desires and needs of their patient-subjects. Indeed, with rare exceptions, their relationships with the patient-subjects appeared to have elements of the depth and sensitivity to which good primary care physicians aspire in their relationships with their patients.
The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
"Overall Assessment of the Trials."
Review of the Fialuridine (FIAU) Clinical Trials.
Washington, DC: The National Academies Press, 1995.
Please select a format: